Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-01-03 @ 5:53 PM
Study NCT ID:
NCT00068757
Status:
COMPLETED
Last Update Posted:
2012-09-12
First Post:
2003-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |